Nice long setup with BCRX:
Technical breakout of range after good quarterly ER. more volume
--> Improved outlook for 2025 and beyond, EPS first time break even
Technical:
Narrow range consolidation around 10$, target ~15$. I anticipate that the gap (9-10) is never closed :-)
Risk: Only one product, and if the upcoming products in the pipeline fails, than run away (as alway at biostocks :-)
Technical breakout of range after good quarterly ER. more volume
--> Improved outlook for 2025 and beyond, EPS first time break even
Technical:
Narrow range consolidation around 10$, target ~15$. I anticipate that the gap (9-10) is never closed :-)
Risk: Only one product, and if the upcoming products in the pipeline fails, than run away (as alway at biostocks :-)
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。